Uncover key developments in the Crohn’s disease therapeutics market, valued at USD 11.59 billion in 2024. Driven by the rising prevalence of Crohn’s disease across the 8 major markets, the industry is set to grow at a CAGR of 3.70%, reaching USD 16.67 billion by 2034. This comprehensive report explores the evolving treatment landscape, including biologics, small molecules, and novel t... https://www.expertmarketresearch.com/reports/crohns-disease-therapeutics-market